お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:ラテンアメリカの心血管インターベンション市場:2030年までの見通し
市場調査レポート
商品コード
980797

ラテンアメリカの心血管インターベンション市場:2030年までの見通し

Latin America Interventional Cardiology Market Outlook 2030

出版日: | 発行: Research Nester | ページ情報: 英文 346 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.33円
ラテンアメリカの心血管インターベンション市場:2030年までの見通し
出版日: 2020年12月10日
発行: Research Nester
ページ情報: 英文 346 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

ラテンアメリカの心血管インターベンションの市場規模は、2019年に約7億米ドルとなり、2021年から2030年の予測期間に8.48%のCAGRで成長すると予測されています。可処分所得の増加により、人々は医療により多くの投資をしています。同市場最大のシェアは、国内における心血管疾患の有病率の高まりにより、現在ブラジルが占めており、実施されている心血管インターベンションの件数も増加しています。

心臓病の最も一般的な形態は冠状動脈疾患であることが知られています。心臓に血液を供給する動脈が閉塞したときに起こります。さらに、同疾患蔓延の高まりは、合併症を減らし、生活の質を向上させることができる革新的な装置および治療に対する需要の増加を生み出しました。心血管疾患の危険因子はラテンアメリカで非常に増加しており、同市場の成長を促進すると予測されています。

当レポートは、ラテンアメリカの心血管インターベンション市場について調査しており、市場規模や予測、動向や機会、成長および抑制要因、デバイス・用途・エンドユーザー・国別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義
  • 市場セグメンテーション
  • 製品の概要

第2章 前提条件・略語

第3章 調査手法

  • 調査プロセス
  • 2次調査
  • 1次調査
  • 市場規模の推計

第4章 エグゼクティブサマリー

第5章 規制状況

第6章 主要な市場機会

  • 地理的な機会
  • 戦略的な競争の機会

第7章 リスク分析

  • 需要リスク分析
  • 供給リスク分析

第8章 Covid-19の影響分析

第9章 心血管障害の疫学分析

第10章 市場力学の分析

  • 成長要因
  • 抑制要因/課題
  • 主な動向

第11章 価格分析

第12章 市場の見通し

  • 市場規模と予測、2018-2030f
    • 売上別
    • 取引量別
  • デバイス別
    • 血管形成バルーン(2015-2030f)
      • 従来型/一般型バルーン
      • バルーンの切断とスコアリング
      • 薬剤溶出性バルーン
    • 血管形成術ステント(2015-2030f)
      • 薬剤溶出性ステント
      • ベアメタルステント
      • 生体吸収性ステント
    • カテーテル(2015-2030f)
      • 診断用カテーテル
      • 血管造影カテーテル
      • IVUS–OCTカテーテル
      • ガイディングカテーテル
    • プラーク改善装置(2015-2030f)
      • 血栓摘出装置
      • アテレクトミーデバイス
    • 血行動態改善装置(2015-2030f)
      • 塞栓保護デバイス
      • 慢性完全閉塞デバイス
    • ガイドワイヤー(2015-2030f)
    • その他(血管閉鎖装置など)(2015-2030f)
  • 用途別(2015-2030f)
    • 冠状動脈疾患
    • 末梢動脈疾患
    • 神経血管疾患
    • その他
  • エンドユーザー別(2015-2030f)
    • カテーテル検査室
    • 病院
    • クリニック
    • 外来手術センター
  • 国別(2015-2030f)
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • チリ
    • ペルー
    • エクアドル
    • ベネズエラ
    • ドミニカ共和国
    • グアテマラ
    • パナマ
    • コスタリカ
    • ウルグアイ
    • その他ラテンアメリカ

第13章 競合考察

  • 市場シェア分析
  • 地域ごとの主要メーカーの評価
  • 地域市場の競合評価
    • ABBOTT
    • BOSTON SCIENTIFIC CORPORATION
    • MERIT MEDICAL
    • BIOSENSORS INTERNATIONAL GROUP, LTD.
    • TERUMO EUROPE NV
    • MEDTRONIC
    • CORDIS
    • BIOTRONIK
    • その他の市場企業

第14章 アナリストレビュー

目次

Interventional cardiology market comprises of products that are used in catheter-based diagnosis & treatments of various cardiac disorders under coronary artery disease, vascular disease and acquired structural heart disease. In 2019, the Latin America Interventional Cardiology Market accounted for a market value of around USD 700 million and is expected to grow at a CAGR of 8.48% over the forecast period of 2021-2030. People are investing more on medical care owing to the growing disposable income. The largest share of the Latin American interventional cardiology market is currently owned by Brazil, owing to the increasingly growing prevalence of cardiovascular diseases in the nation, which has also led to an increase in the number of interventional cardiology procedures being implemented.

The Latin America interventional cardiology market consists of various segments that are segmented by devices, application and end user. The market is further segmented by devices into angioplasty balloons, angioplasty stents, catheters, plaque modification devices, hemodynamic flow alteration devices, guidewires, and others, out of which, angioplasty balloons accounted for a market share of around 30% in 2019. The angioplasty balloons consist of old/normal balloons, cutting and scoring balloons, and drug-eluting balloons. Angioplasty balloons are highly used in angioplasty procedures to restore blood flow into the heart. A surge in their demand has been generated by their increasing application in cardiology.

On the basis of application, the market is segmented into coronary artery disease, peripheral artery disease, neurovascular disease and others, out of which, coronary artery disease accounted for a market share of around 45% in 2019 and expected to grow by a significant CAGR over the forecast period. The most prevalent form of heart disease is known to be coronary artery disease. It happens when the arteries that supply blood to the heart gets a blockage. Furthermore, the growing prevalence of the disease has generated an increase in demand for innovative devices and treatments which can reduce complications and improve the quality of life. In addition, risk factors for cardiovascular diseases are extremely prevalent in Latin America, which is also projected to drive the growth of Latin America interventional cardiology market.

The advancements in technology in the healthcare sector and increasing research and development investments have created an upsurge in the growth of the Latin America interventional cardiology market. The rapidly increasing prevalence of cardiovascular diseases is consistently attracting various market players in the interventional cardiology market who are incorporating multiple research and development activities coupled with different technologies to improve their product portfolio. Additionally, various market players are making huge investments to reduce the cost of the product so that key application-based end markets can use it. This factor is projected to drive the growth of the market in the upcoming years.

However, lack of skilled cardiovascular surgeons to perform interventional cardiology procedures and high risk of infection in patients after the procedure are estimated to act as barriers to the growth of the Latin America interventional cardiology market during the forecast period.

Some of the affluent leaders in the Latin America Interventional Cardiology Market are: Boston Scientific Corporation, Merit Medical Systems, Biosensors International Group, Ltd., Terumo Europe NV, Medtronic, Cardinal Health (Cordis), BIOTRONIK SE & Co KG, and others.

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation
  • 1.3. Product Overview

2. Assumptions And Acronyms

3. Research Methodology

  • 3.1. Research Process
  • 3.2. Secondary Research
  • 3.3. Primary Research
  • 3.4. Market Size Estimation

4. Executive Summary- Latam Interventional Cardiology Market

5. Regulatory Landscape

6. Key Market Opportunities

  • 6.1. Geographic Opportunities
  • 6.2. Strategic Competitive Opportunities

7. Risk Analysis

  • 7.1. Demand Risk Analysis
  • 7.2. Supply Risk Analysis

8. Impact Analysis Of Covid-19 On The Market

9. Epidemiology Analysis Of Cardiovascular Disorders

10. Analysis Of Market Dynamics

  • 10.1. Growth Drivers
  • 10.2. Restraints/Challenges
  • 10.3. Key Trends

11. Pricing Analysis

12. LATAM Interventional Cardiology Market Outlook

  • 12.1. Market Size And Forecast, 2018-2030f
    • 12.1.1. By Value (USD Million)
    • 12.1.2. By Volume (Million Units)
      • 12.1.2.1. Latin America Interventional Cardiology Market, 2015-2030f (USD Million & Million Units)
      • 12.1.2.1.1. Market Overview
      • 12.1.2.1.2. Assessment Of Macroeconomic Factors Of Countries
      • 12.1.2.1.3. Regional Growth Prospects
      • 12.1.2.1.4. List Of Key Players
      • 12.1.2.1.5. By Market Segmentation
  • Device (Market Size & Market Share)
    • Angioplasty Balloons, 2015-2030f (USD Million & Million Units)
      • Old/Normal Balloons, 2015-2030f (USD Million & Million Units)
      • Cutting And Scoring Balloons, 2015-2030f (USD Million & Million Units)
      • Drug-Eluting Balloons, 2015-2030f (USD Million & Million Units)
    • Angioplasty Stents, 2015-2030f (USD Million & Million Units)
      • Drug-Eluting Stents, 2015-2030f (USD Million & Million Units)
      • Bare-Metal Stents, 2015-2030f (USD Million & Million Units)
      • Bioabsorbable Stents, 2015-2030f (USD Million & Million Units)
    • Catheters, 2015-2030f (USD Million & Million Units)
      • Diagnostic Catheters, 2015-2030f (USD Million & Million Units)
      • Angiography Catheters, 2015-2030f (USD Million & Million Units)
      • Ivus/Oct Catheters, 2015-2030f (USD Million & Million Units)
      • Guiding Catheters, 2015-2030f (USD Million & Million Units)
    • Plaque Modification Devices, 2015-2030f (USD Million & Million Units)
      • Thrombectomy Devices, 2015-2030f (USD Million & Million Units)
      • Atherectomy Devices, 2015-2030f (USD Million & Million Units)
    • Hemodynamic Flow Alteration Devices, 2015-2030f (USD Million & Million Units)
      • Embolic Protection Devices, 2015-2030f (USD Million & Million Units)
      • Chronic Total Occlusion Devices, 2015-2030f (USD Million & Million Units)
    • Guidewires, 2015-2030f (USD Million & Million Units)
    • Others (Vascular Closure Devices, Etc.), 2015-2030f (USD Million & Million Units)
  • Application (Market Size & Market Share)
    • Coronary Artery Disease, 2015-2030f (USD Million & Million Units)
    • Peripheral Artery Disease, 2015-2030f (USD Million & Million Units)
    • Neurovascular Disease, 2015-2030f (USD Million & Million Units)
    • Others, 2015-2030f (USD Million & Million Units)
  • End-Users (Market Size & Market Share)
    • Catheterization Laboratories, 2015-2030f (USD Million & Million Units)
    • Hospitals, 2015-2030f (USD Million & Million Units)
    • Clinics, 2015-2030f (USD Million & Million Units)
    • Ambulatory Surgical Centers, 2015-2030f (USD Million & Million Units)
  • Country
    • Brazil, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Mexico, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Argentina, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Colombia, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Chile, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Peru, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Ecuador, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Venezuela, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Dominican Republic, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Guatemala, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Panama, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Costa Rica, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Uruguay, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)
    • Rest Of Latin America, 2015-2030f (USD Million & Million Units)
  • Device (Market Size & Market Share)
  • Application (Market Size & Market Share)
  • End-Users (Market Size & Market Share)

13. Competitive Insights

  • 13.1. Market Share Analysis
  • 13.2. Assessment Of The Region-Wise Key Manufacturers
  • 13.3. Evaluation Of The Regional Competitors Of The Market
    • 13.3.1. ABBOTT
      • 13.3.1.1. Business Overview
      • 13.3.1.2. Products Offered
      • 13.3.1.3. Key Clients & Partners
      • 13.3.1.4. Financials
      • 13.3.1.5. Business Strategy
      • 13.3.1.6. Recent News & Developments
      • 13.3.1.7. Key Performance Indicators
      • 13.3.1.8. Geographical Presence
    • 13.3.2. BOSTON SCIENTIFIC CORPORATION
    • 13.3.3. MERIT MEDICAL
    • 13.3.4. BIOSENSORS INTERNATIONAL GROUP, LTD.
    • 13.3.5. TERUMO EUROPE NV
    • 13.3.6. MEDTRONIC
    • 13.3.7. CORDIS
    • 13.3.8. BIOTRONIK
    • 13.3.9. Other Market Players

14. Analyst Review

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.